Valneva
development outlook pivotal phase trial topline read out expected mid | Valneva
Company
Deck Type
IPO
Sector
Industry
Deck date
April 2021
Slide
23 of 41
Related slides by other companies
Imara
Mergers and Acquisitions
October 2022
clinical development strategy i | Imara
Larimar Therapeutics
Investor Presentation
November 2023
phase dose exploration trial advances and initiation of long term open label extension trial remains on track | Larimar Therapeutics
MindMed
Investor Presentation
November 2024
phase trial schematic schematic | MindMed
Oculis
Investor Conference
June 2023
development status | Oculis
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights